share_log

Kiora Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Gayron Kenneth L

SEC announcement ·  Oct 3, 2023 16:44
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more